• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 85 of 100

U.S. Multinationals in Puerto Rico
Health

FDA Approves New Eli Lilly Drug for Advanced Lung Cancer

By Laura Lorenzetti
November 24, 2015
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Bill Ackman Just Boosted His Valeant Stake

By Reuters
November 24, 2015
Pfizer In Merger Talks With Allergan PLC
Health

Pfizer, Allergan Confirm $160 Billion Merger Deal

By Geoffrey Smith and Claire Groden
November 23, 2015
Pfizer In Merger Talks With Allergan PLC
Leadership

Pfizer, Allergan Poised for $150 Billion Merger

By Claire Groden
November 22, 2015
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck CEO Blasts Company that Raised Drug Prices 5,000%

By Laura Lorenzetti
November 21, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca, Sanofi Add New Twist to Pharma Merger Mania

By Reuters and Fortune Editors
November 20, 2015
MSMB Capital Management CIO Martin Shkreli
Finance

Turing CEO Invested in This Penny Stock Biotech to Keep It Alive

By Laura Lorenzetti
November 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Leadership

A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes

By Alan Murray
November 19, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership

The Treasury Will Crack Down on ‘Tax Inversions’ This Week

By Geoffrey Smith
November 19, 2015
571977919
Health

Global Drug Spending Will Reach $1.4 Trillion by 2020

By Laura Lorenzetti
November 18, 2015
Police Operation in Saint Denis
Tech

Paris Siege and Square Prices IPO–5 Things to Know Today

By Laura Lorenzetti and Geoffrey Smith
November 18, 2015
Flibanserin
Health

Why ‘Female Viagra’ Is Not Selling

By Robert Hackett
November 17, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance

Why Mylan Just Lost The Largest Hostile Takeover Battle Ever

By Jen Wieczner
November 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership

Mylan, Valeant and Theranos: What the Heck, Biotech?

By Jeffrey Sonnenfeld
November 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health

Mylan’s Hostile Bid for Perrigo Fails

By Reuters
November 13, 2015

Most Popular

  • AI
    Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
    By Eva Roytburg
  • Economy
    Trump's social security chief says 'everything' is on the table and retirement is about to get a 'different set of...
    By Eleanor Pringle
  • Economy
    Ray Dalio says the world is running out of interest in buying U.S. debt—but America is unable to cut back its spending
    By Eleanor Pringle
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.